Nova Patents
IL291822B2

Use of agent for induction of specific immunity against severe acute respiratory syndrome sars-cov-2 for population revaccination (versions)

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
WO0166137A1CitesWorld Intellectual Property Organization (WIPO)YSearch report1-7
WO2006086284A2CitesWorld Intellectual Property Organization (WIPO)YSearch report1-7
WO2007104792A2CitesWorld Intellectual Property Organization (WIPO)YSearch report1-7
WO2021002776A1CitesWorld Intellectual Property Organization (WIPO)XSearch report1-6
RU2720614C1CitesRussian Federation–Search report–
ABBINK, PETER, ET AL., COMPARATIVE SEROPREVALENCE AND IMMUNOGENICITY OF SIX RARE SEROTYPE RECOMBINANT ADENOVIRUS VACCINE VECTORS FROM SUBGROUPS B AND D., 31 December 2007 (2007-12-31)Non-patent––Search report–
TATSIS, NIA, AND HILDEGUND CJ ERTL., ADENOVIRUSES AS VACCINE VECTORS., 14 August 2004 (2004-08-14)Non-patent––Search report–
GEISBERT, THOMAS W., ET AL., RECOMBINANT ADENOVIRUS SEROTYPE 26 (AD26) AND AD35 VACCINE VECTORS BYPASS IMMUNITY TO AD5 AND PROTECT NONHUMAN PRIMATES AGAINST EBOLAVIRUS CHALLENGE., 16 February 2011 (2011-02-16)Non-patent––Search report–